Incanthera PLC eyes huge market for cancer-prevention suncream proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Runtime 15:26
In an interview with London South East, the Incanthera Chairman Tim McCarthy and CEO Dr Simon Ward put the Aquis-listed cancer drug company in context and explain about the successful clinical trials of their skin cancer cream Sol.
Incanthera are a cancer drug development specialist which was spun out of the Institute of Cancer Therapeutics on the Bradford University campus 10 years ago.
Tim McCarthy, Chairman said: We look at targeted medicines in the onclogy field. We want to target those medicines so that we get the results we are looking for in the most efficient and safe way. The aim of the company is to deliver medicines which are more effective than we currently have. The market for these drugs is clearly enormous, so if we get it right we will have it right for both patients and investors as well.